OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression. (linkinghub.elsevier.com)

Authors: Liu L … Zhang Y Journal: Drug Resistance Updates Published: 2026-08-09 DOI: https://doi.org/10.1016/j.drup.2026.101469